Six men and one woman with mild anemia due to β-thalassemia trait and major iron overload attributable to concomitant primary hemochromatosis were treated by erythrocytapheresis to remove iron, combined with subcutaneous desferrioxamine in the four cases with greater iron load. Depletion was achieved by iron removal of 4.5-15.1 g after 9-24 months' treatment. No side effects were observed, suggesting that such a regimen is effective and safe in this particular subgroup of hemochromatotics.
|Number of pages||3|
|Journal||American Journal of Gastroenterology|
|Publication status||Published - 1989|
ASJC Scopus subject areas